We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
+7.07%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.69%
AUM
$17.4B
AUM Growth
+$359M
(+2.1%)
Cap. Flow
-$480M
Cap. Flow
% of AUM
-2.77%
Top 10 Holdings %
Top 10 Hldgs %
19.12%
Holding
357
New
45
Increased
93
Reduced
141
Closed
56
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$141M |
| 2 |
DFS
Discover Financial Services
DFS
|
+$129M |
| 3 |
Biogen
BIIB
|
+$126M |
| 4 |
United Therapeutics
UTHR
|
+$124M |
| 5 |
Whirlpool
WHR
|
+$106M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CBST
CUBIST PHARMACEUTICALS INC
CBST
|
+$274M |
| 2 |
ENDP
Endo International plc
ENDP
|
+$207M |
| 3 |
SHPG
Shire pic
SHPG
|
+$206M |
| 4 |
MWIV
MWI VETERINARY SUPPLY, INC.
MWIV
|
+$137M |
| 5 |
JPMorgan Chase
JPM
|
+$132M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.8% |
| 2 | Technology | 14.71% |
| 3 | Consumer Discretionary | 13.45% |
| 4 | Industrials | 12.27% |
| 5 | Communication Services | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Signet Jewelers
SIG
$3.65B
| $76.7M | 0.44% |
552,698
-149,545
| -21% | -$18.5M |
|
77
CBRE Group
CBRE
$42.7B
| $76.2M | 0.44% |
1,969,520
-75,167
| -4% | -$2.59M |
|
78
CNX Resources
CNX
$5.2B
| $75.4M | 0.43% |
3,242,954
-940,443
| -22% | -$24M |
|
79
Timken Company
TKR
$8.92B
| $73.4M | 0.42% |
1,742,459
+316,705
| +22% | +$13.1M |
|
80
Lennox International
LII
$15.1B
| $72.9M | 0.42% |
+652,913
| New | +$67.3M |
|
81
Vulcan Materials
VMC
$36.5B
| $72.8M | 0.42% |
863,286
+225,861
| +35% | +$17.4M |
|
82
Align Technology
ALGN
$12B
| $71.9M | 0.41% |
1,337,661
+270,561
| +25% | +$15.4M |
|
|
WBC
83
DELISTED
WABCO HOLDINGS INC.
WBC
| $71.5M | 0.41% |
581,645
+269,051
| +86% | +$29.2M |
|
84
TransDigm Group
TDG
$69.8B
| $71.2M | 0.41% |
325,313
-25,790
| -7% | -$5.43M |
|
|
ALEX
85
DELISTED
Alexander & Baldwin
ALEX
| $70.9M | 0.41% |
1,640,829
+102,958
| +7% | +$4.09M |
|
86
Community Health Systems
CYH
$416M
| $69.2M | 0.4% |
1,602,683
-169,460
| -10% | -$7.02M |
|
87
Packaging Corp of America
PKG
$22.5B
| $69.1M | 0.4% |
884,337
-74,620
| -8% | -$5.92M |
|
|
MJN
88
DELISTED
Mead Johnson Nutrition Company
MJN
| $67.8M | 0.39% |
674,139
-19,124
| -3% | -$1.93M |
|
|
WMGI
89
DELISTED
Wright Medical Group Inc
WMGI
| $67.1M | 0.39% |
2,600,554
-156,100
| -6% | -$4.02M |
|
|
PAY
90
DELISTED
Verifone Systems Inc
PAY
| $67M | 0.39% |
1,921,123
+37,612
| +2% | +$1.3M |
|
91
Prothena Corp
PRTA
$449M
| $66.2M | 0.38% |
1,734,928
+656,378
| +61% | +$16.8M |
|
92
Brunswick
BC
$5.26B
| $66.1M | 0.38% |
1,284,013
+666,181
| +108% | +$35.4M |
|
93
Pacira BioSciences
PCRX
$1.02B
| $64.7M | 0.37% |
+727,990
| New | +$73.9M |
|
|
MDRX
94
DELISTED
Veradigm Inc. Common Stock
MDRX
| $63M | 0.36% |
5,264,105
-504,208
| -9% | -$6.16M |
|
95
Liberty Global Class C
LBTYK
$3.58B
| $62.7M | 0.36% |
1,555,974
-59,540
| -4% | -$2.36M |
|
96
Raymond James Financial
RJF
$34.5B
| $62M | 0.36% |
1,638,561
-8,477
| -0.5% | -$317K |
|
|
RHT
97
DELISTED
Red Hat Inc
RHT
| $61.7M | 0.36% |
814,393
+43,858
| +6% | +$2.97M |
|
98
Autodesk
ADSK
$51.2B
| $61.5M | 0.35% |
1,048,443
+39,570
| +4% | +$2.34M |
|
99
Vail Resorts
MTN
$5.23B
| $61.2M | 0.35% |
+591,625
| New | +$53.6M |
|
|
AEGR
100
DELISTED
Aegerion Pharmaceuticals
AEGR
| $60.8M | 0.35% |
2,323,633
-432,300
| -16% | -$11M |
|
Similar funds
OAG
JG
CHP
SC
Westfield Capital Management's Q1 2015 Portfolio in Review
As of Q1 2015, Westfield Capital Management held 357 positions worth $17.4B, up 2.1% from $17B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Westfield Capital Management's Q1 2015 filing shows 45 new, 93 increased, 141 reduced and 56 closed positions. Its largest new stake was Mastercard: 1,619,899 shares worth $140M. The largest sale was CUBIST PHARMACEUTICALS INC, an estimated $274M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.
- Westfield Capital Management's largest Q1 2015 buy was Mastercard: 1,619,899 shares worth $140M.
- Westfield Capital Management added most to Biogen in Q1 2015, an estimated $126M increase.
- Westfield Capital Management's biggest Q1 2015 reduction was Shire pic, cutting an estimated $206M.
- Westfield Capital Management fully exited CUBIST PHARMACEUTICALS INC in Q1 2015, selling an estimated $274M.
- Westfield Capital Management's ten largest holdings make up 19% of its $17.4B portfolio in Q1 2015.
- Westfield Capital Management opened 45 new positions and closed 56 in Q1 2015.
- Westfield Capital Management's portfolio value rose 2.1% quarter-over-quarter to $17.4B.
Based on Westfield Capital Management's 13F filing for Q1 2015, filed 13 May 2015.